Interfant-99 was an international collaborative treatment protocol for infants with acute lymphoblastic leukemia (ALL).

Lönnerholm, G., Valsecchi, M., De Lorenzo, P., Schrappe, M., Hovi, L., Campbell, M., et al. (2009). Pharmacokinetics of high-dose methotrexate in infants treated for acute lymphoblastic leukemia. PEDIATRIC BLOOD & CANCER, 52(5), 596-601 [10.1002/pbc.21925].

Pharmacokinetics of high-dose methotrexate in infants treated for acute lymphoblastic leukemia

VALSECCHI, MARIA GRAZIA;
2009

Abstract

Interfant-99 was an international collaborative treatment protocol for infants with acute lymphoblastic leukemia (ALL).
Articolo in rivista - Articolo scientifico
Treatment Outcome; Male; Antineoplastic Agents; Infant; Female; Dose-Response Relationship, Drug; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Humans
English
2009
52
5
596
601
none
Lönnerholm, G., Valsecchi, M., De Lorenzo, P., Schrappe, M., Hovi, L., Campbell, M., et al. (2009). Pharmacokinetics of high-dose methotrexate in infants treated for acute lymphoblastic leukemia. PEDIATRIC BLOOD & CANCER, 52(5), 596-601 [10.1002/pbc.21925].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/21504
Citazioni
  • Scopus 18
  • ???jsp.display-item.citation.isi??? 17
Social impact